🇺🇸 FDA
Pipeline program

A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without rabeprazole.

67953964MDD1011

Phase 1 other active

Quick answer

A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without rabeprazole. for Healthy Adult Participants. is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag International N.V.
Indication
Healthy Adult Participants.
Phase
Phase 1
Modality
other
Status
active

Clinical trials